Japan · Delayed Price · Currency is JPY Modalis Therapeutics Statistics
Total Valuation
TYO:4883 has a market cap or net worth of JPY 4.03 billion. The enterprise value is 1.22 billion.
| Market Cap | 4.03B |
| Enterprise Value | 1.22B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4883 has 89.55 million shares outstanding. The number of shares has increased by 45.98% in one year.
| Current Share Class | 89.55M |
| Shares Outstanding | 89.55M |
| Shares Change (YoY) | +45.98% |
| Shares Change (QoQ) | +7.04% |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | 10.94% |
| Float | 81.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 25.13
| Current Ratio | 25.13 |
| Quick Ratio | 24.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -188.52 |
Financial Efficiency
Return on equity (ROE) is -59.66% and return on invested capital (ROIC) is -39.28%.
| Return on Equity (ROE) | -59.66% |
| Return on Assets (ROA) | -36.26% |
| Return on Invested Capital (ROIC) | -39.28% |
| Return on Capital Employed (ROCE) | -67.92% |
| Weighted Average Cost of Capital (WACC) | 6.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -107.22M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:4883 has paid 565,000 in taxes.
| Income Tax | 565,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.19% in the last 52 weeks. The beta is 0.36, so TYO:4883's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -39.19% |
| 50-Day Moving Average | 58.30 |
| 200-Day Moving Average | 67.56 |
| Relative Strength Index (RSI) | 34.15 |
| Average Volume (20 Days) | 7,341,110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.92B |
| Pretax Income | -1.82B |
| Net Income | -1.82B |
| EBITDA | n/a |
| EBIT | -1.92B |
| Earnings Per Share (EPS) | -22.39 |
Balance Sheet
The company has 2.81 billion in cash and n/a in debt, with a net cash position of 2.81 billion or 31.40 per share.
| Cash & Cash Equivalents | 2.81B |
| Total Debt | n/a |
| Net Cash | 2.81B |
| Net Cash Per Share | 31.40 |
| Equity (Book Value) | 2.80B |
| Book Value Per Share | 31.47 |
| Working Capital | 2.78B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4883 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.98% |
| Shareholder Yield | -45.98% |
| Earnings Yield | -45.23% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |